Adrien Lemaignen

Head of Department / MD-PhD

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Adrien Lemaignen serves as the Head of Department at CHRU de Tours in France. He holds an MD-PhD and specializes in the fields of infectious diseases and antibiotic therapy. His recent research includes studies on therapeutic drug monitoring for endocarditis, multidrug-resistant osteoarticular tuberculosis, and the management of complex bone and joint infections. Dr. Lemaignen is actively involved in advancing clinical practices through evidence-based research in hospital settings.

Articles (7)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Alexandra Aubry

Professor

Sorbonne Université Faculté de Médecine

FRANCE

View details

Pascale Bémer

Nantes University Hospital

FRANCE

View details

Leslie Guillon-Grammatico

FRANCE

View details

Pascal Astagneau

Professor of medicine

Sorbonne Université

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adrien Lemaignen

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Amoxicillin therapeutic drug monitoring for endocarditis: A comparative study (EI-STAB)

Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France

Chronic subcutaneous infection of Purpureocillium lilacinum in an immunocompromised patient: Case report and review of the literature

Inter-expert agreement on indications for antibiotic therapy in older adults admitted to French hospital through an emergency department

Computerized registry as a potential tool for surveillance and management of complex bone and joint infections in France

Risk factors and outcomes of early acute kidney injury in infective endocarditis: a retrospective cohort study

Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials

Collaborators (4)

Alexandra Aubry

Pascale Bémer

Leslie Guillon-Grammatico

Pascal Astagneau

Make your next move.